Updated:
BioCrossroads
BioCrossroads is a private equity asset manager headquartered in Indianapolis.
BioCrossroads
BioCrossroads is a public-private collaboration in Indiana that supports life sciences businesses and new development. It provides funding and support to life sciences companies, launches new enterprises, and promotes science education. BioCrossroads has made 32 investments, including a Series A investment in Gate Neurosciences in September 2022, and has facilitated 6 portfolio exits, including MBX Biosciences in September 2024.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Indianapolis
Corporate office
Indianapolis, United States
Sector focus
Frequently asked questions
What is BioCrossroads?
BioCrossroads is a private equity headquartered in Indianapolis, United States.
Where is BioCrossroads headquartered?
BioCrossroads is headquartered in Indianapolis, United States, in the North America region.
What is BioCrossroads's assets under management?
BioCrossroads reports approximately Undisclosed in assets under management, as tracked by Altss.
What does Altss track for BioCrossroads?
Altss maintains an OSINT-verified profile of BioCrossroads covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is BioCrossroads's website?
BioCrossroads's public website is www.biocrossroads.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is BioCrossroads?
BioCrossroads is classified by Altss as a Private Equity, operating from United States within the North America region.
How does Altss source intelligence on BioCrossroads?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was BioCrossroads's Altss profile last updated?
BioCrossroads's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: